Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Randomized Study of Neoadjuvant Metformin Plus Letrozole vs Placebo Plus Letrozole for ER-positive Postmenopausal Breast Cancer

NCT01589367 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT01589367
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01589367 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Randomized Study of Neoadjuvant Metformin Plus Letrozole vs Placebo Plus Letrozole for ER-positive Postmenopausal Breast Cancer
Lead sponsor
Seoul National University Hospital
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2012
Completion date
August 31, 2018
Enrollment
208 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hormone receptor positive malignant neoplasm of breast